It integrates perfectly the protein quantity and quality of hypocaloric diets. It integrates in the sportsman the increased need of amino acids resulting from intense muscle work. The composition of NEPISOND is optimized to promote the GH synthesis (growth hormone), protein anabolism and fatty acid metabolism.The intake of serum proteins and particular amino acids such as arginine, ornithine, citrulline and taurine, vitamin B6 and zinc induces the highest secretion of GH.
The increase in GH leads to an inhibition of transcriptase for adipogenesis, stimulated by insulin and estrogen, resulting in mobilization of fat from the hormone dependent areas. The presence of carnitine, policosanols and coenzyme Q10 optimizes lipid metabolism and catabolism of fatty acids at the mitochondrial level.
It is a protein nutritional support with a high content of cysteine (3.3%), which stimulates the synthesis of glutathione, the most powerful natural antioxidant, by suitably integrating the diet of immunocompromised and malnourished patients.
It preserves the elasticity and hydration of collagen present in the subcutaneous connective tissue.
As a supplement to implement the tone of the subcutaneous connective tissue and muscles it is preferable to cyclically use a measure of 10 g of NEPISOND dissolved together with the COLPLUS in water or in a vial of liquid yogurt, before going to sleep, to optimize the stimulus of synthesis of collagen and GH, which occurs predominantly during the night.
The NEPISOND is presented in a 500 g jar of palatable and easily soluble powder. The taste can be further improved by adding coffee or bitter cocoa to the solution.
The presence of FOS preserves the intestinal function during the aglucidical nutritional therapies (TNA), carried out orally or with a tube, exclusively with nutritional amino-protein supplements for the treatment of the great obesity, in bariatric surgery and for the nutritional therapy of psoriasis, fibromyalgia, PCOS, infertility and other complex metabolic, inflammatory and chronic degenerative diseases.